Team:Heidelberg/Sponsors

Physicist Dr. h.c. Klaus Tschira established the Klaus Tschira Foundation in 1995 as a not-for-profit organization designed to support research in informatics, the natural sciences, and mathematics, as well as promotion of public understanding in these sciences. Klaus Tschira’s commitment to this objective was honored in 1999 with the „Deutscher Stifterpreis” by the National Association of German Foundations. The home of the Foundation is the Villa Bosch in Heidelberg, the former residence of Nobel Prize laureate for chemistry Carl Bosch (1874–1940). Klaus Tschira is a co-founder of the SAP AG in Walldorf, one of the world’s leading companies in the software industry. After many years on the board of directors, Klaus Tschira is now a member of the company’s supervisory board.

Powering Life Science & Bioinformatics Workflows

Dramatic advances in next gen sequencing technologies, ever-greater microscopy resolutions and a many-fold increase in the number of medical imaging devices are driving unprecedented growth of critical file-based research data. Isilon scale-out NAS solutions dramatically increase the productivity of mission-critical life science and bioinformatics research applications and workflows by 50 percent while driving down complexity and cost by one-third. Designed specifically to meet the challenges typical of life science and bioinformatics organizations, Isilon offers the only "pay-as-you-grow" model for adding storage capacity quickly and easily. Isilon's range of capabilities for accessing online, nearline, and long-term data helps you to configure just the right solution for your needs, and cost-effectively adapt as your needs change. When it comes to achieving exceptional productivity for mission critical research applications and workflows, Isilon's award-winning solutions deliver.

Die LANGE + PFLANZ Werbeagentur GmbH ist seit 1992 Spezialist für Marketing + Design. Unsere Schwerpunkte liegen in den Bereichen Finanzkommunikation, Unternehmenskommunikation und Strategische Kommunikation. Als inhabergeführte Kommunikationsagentur bieten wir individuelle und nachhaltige Kommunikationslösungen auf unterschiedlichen medialen Plattformen.

Steinbeis ist heute mit seinem Netzwerk weltweit im Wissens- und Technologietransfer aktiv. Den Grundstein dafür legte der Namensgeber Ferdinand von Steinbeis schon im 19. Jahrhundert: Sein Engagement als Wirtschaftsförderer dankten ihm Unternehmer mit einem finanziellen Beitrag, der die Gründung der ersten Steinbeis-Stiftung 1868 zur Förderung der gewerblichen Ausbildung von Jugendlichen möglich machte.

Graffinity is the premier partner for fragment based drug discovery and lead development of small molecule pharmaceuticals. Graffinity has built a unique approach which includes chemical microarrays, fragment screening, SPR label-free imaging of protein-ligand interactions, computational chemistry and lead discovery. The technology platform offers a new drug discovery paradigm for the rapid conversion of genomic information into novel, high quality leads and drug candidates. Graffinity applies this technology in established high-profile collaborations with leading Pharma and Biotech companies.

Amnis designs, manufactures and markets leading cell imaging instrumentation for the research and clinical markets. The Company’s flagship product is the ImageStream system, which combines the speed and sensitivity of flow cytometry with the power of high resolution digital microscopy. As the only technology capable of imaging cells at high speed directly in bodily fluids, ImageStream enables unique, non-invasive diagnostic applications. These applications include residual disease detection via high throughput FISH, circulating endothelial cell and tumor cell analysis, and advanced automated hematology based on multi-color phenotyping combined with histochemical staining.

Focused on patients’ needs, sanofi-aventis offers a range of essential healthcare assets, including a broad-based product portfolio and a worldwide presence. Sanofi-aventis products and services are centered on patients. Our ambition: to become a diversified global healthcare leader.

The future since 1386
Soon after its foundation, the University had firmly established its position in Europe's intellectual landscape. In the initial period, renowned theologians and jurists figured prominently among the Elector's counsellors, while the list of alumni included chancellors, bishops and royal emissaries. Later, in the 15th century, Heidelberg developed into a stronghold of humanism.

In addition to the experimental acquisition of biological data and their analysis with bio-statistical and bio-computational methods, the modelling and simulation of these processes as well as their validation have become more important than ever before. For small systems such as single molecules and small complexes, molecular models have already provided significant insights leading not only to a better understanding of interactions, but also to the rational design of new drugs. For more complex systems (large molecular complexes, cells, organs and populations), such analysis is only preliminary. On this basis, the University of Heidelberg has established the research network for the "Quantitative Analysis of Molecular and Cellular Biological Systems (BIOQUANT)" which integrates research groups from different disciplines and help them to focus on these research tasks.